Related Experiment Video

Updated: Jun 23, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Altered gene and protein expression by Nm23-H1 in metastasis suppression

Jong Heun Lee1, Jean-Claude Marshall, Patricia S Steeg

  • 1Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Room 1122, Bethesda, MD 20892, USA.

Insights

Metastasis suppressor genes like Nm23-H1 inhibit cancer spread by downregulating EDG2 and potentially influencing mRNA splicing. Restoring EDG2 counteracts Nm23-H1’s metastasis-suppressive effects, highlighting its role in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis suppressor genes (MSG) inhibit cancer spread without affecting primary tumor growth.
  • Nm23-H1 is the first identified MSG, known to modulate gene and protein expression in cancer cells.

Purpose of the Study:

  • To investigate the molecular mechanisms by which Nm23-H1 suppresses metastasis.
  • To identify downstream targets of Nm23-H1 and their role in metastasis.

Main Methods:

  • Microarray expression profiling to identify downregulated genes.
  • In vivo metastasis assays (pulmonary colonization and spontaneous metastasis).
  • Isotope Capture Affinity Tag (ICAT) proteomic analysis to identify differentially expressed proteins.

Main Results:

  • Nm23-H1 was found to downregulate EDG2, which encodes a lysophosphatidic acid (LPA) receptor.
  • Reintroducing EDG2 into Nm23-H1-expressing cells reversed the metastasis suppressive phenotype.
  • ICAT analysis identified GEMIN5, a protein involved in mRNA splicing, as differentially regulated.

Conclusions:

  • EDG2 plays a critical role in mediating the metastasis suppressive function of Nm23-H1.
  • Nm23-H1 may influence cancer metastasis through the regulation of RNA processing proteins and alternative mRNA splicing.
  • Further research into Nm23-H1's role in RNA processing could reveal new therapeutic strategies for cancer metastasis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...